Learning Outcomes:
On successful completion of the module students should be able to:
1. Demonstrate a comprehensive understanding of the molecular mechanisms of proteinopathy in neurodegenerative diseases.
2. Discuss in depth the role of protein aggregation and failed protein clearance in neurodegenerative proteinopathies.
3. Critically evaluate recent research findings into the molecula, genetic and cellular disruptions which underpin these disorders.
4. Demonstrate an understanding of the developments in novel therapeutic strategies for neurodegenerative proteinopathies.
Indicative Module Content:
Lecture 1: Prion neuroproteinopathies (NO’S)
Lectures 2+3: Alzheimer's disease (GB)
Lecture 4: Developing therapies for neurodegenerative proteinopathies I (NO'S)
Lectures 5+6: Parkinson's disease (GB)
Lectures 7+8 – Huntington protein (NO'S)
Lectures 9+10 – Motor neuron disease (NO'S)
Lecture 11 – Developing therapies for neurodegenerative proteinopathies II (NO'S)
Lecture 12: Tutorial on assessment strategy (NO’S+GB)